❌

Reading view

There are new articles available, click to refresh the page.

How A.I. Is Revolutionizing Drug Development

In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway.

Chips in a container at Terray Therapeutics in Monrovia, Calif. Each of the custom-made chips has millions of minuscule wells for measuring drug screening reactions quickly and accurately.

Ampla, a Lender to Consumer Brands, Faces Financial Struggles

Ampla, which lent money to smaller businesses that sold clothing, home furnishings and other items directly to consumers, is struggling financially and seeking a buyer.

Β© Kim Raff for The New York Times

Ben Perkins, the founder of &Collar, a men’s dress shirt company, was told by an Ampla representative last month that his business’s credit line had been frozen.

Friends From the Old Neighborhood Turn Rivals in Big Tech’s A.I. Race

Demis Hassabis and Mustafa Suleyman, who both grew up in London, feared a corporate rush to build artificial intelligence. Now they’re driving that competition at Google and Microsoft.

Β© Left, Enric Fontcuberta/EPA, via Shutterstock; right, Clara Mokri for The New York Times

Demis Hassabis, left, the chief executive of Google DeepMind, and Mustafa Suleyman, the chief executive of Microsoft AI, were longtime friends from London.
❌